Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBNL1 | Q9NR56 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.72 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.70 |
| ▸ | GSR | P00390 | 7/20 | 0.67 |
| ▸ | ACHE | P22303 | 9/20 | 0.59 |
| ▸ | BCHE | P06276 | 6/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18163884 | 1.00 | MBNL1 (0.74) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL2996028 | 0.99 | MBNL1 (0.75) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL20087027 | 0.95 | MBNL1 (0.80) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL20087077 | 0.95 | MBNL1 (0.80) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL20087053 | 0.95 | MBNL1 (0.80) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL22420450 | 0.95 | ADORA2A (0.72) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL7869225 | 0.94 | MBNL1 (0.81) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL17423375 | 0.94 | MBNL1 (0.66) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL22420448 | 0.92 | ADORA2A (0.72) | MBNL1MEN1KMT2ATDP1ADORA2A | |
| SCHEMBL18163846 | 0.92 | ADORA2A (0.78) | MBNL1MEN1KMT2ATDP1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663043-A | ADMINISTERING CATIONIC LIPOPLYAMINES OR SPECIFIED ACRIDINE COMPOUMDS, ACTIVATION | HEMASURE INC. (US) | 1997-09-02 | — | — | US | claimed |
| WO-1996020592-A1 | METHOD FOR INACTIVATING NON-ENVELOPED VIRUSES USING A VIRICIDE-POTENTIATING AGENT | HEMASURE INC. (US) | 1996-07-11 | — | — | WO | claimed |
| US-5663043-A | ADMINISTERING CATIONIC LIPOPLYAMINES OR SPECIFIED ACRIDINE COMPOUMDS, ACTIVATION | HEMASURE INC. (US) | 1997-09-02 | — | — | US | disclosed |
| WO-1996020592-A1 | METHOD FOR INACTIVATING NON-ENVELOPED VIRUSES USING A VIRICIDE-POTENTIATING AGENT | HEMASURE INC. (US) | 1996-07-11 | — | — | WO | disclosed |